https://www.selleckchem.com/pr....oducts/deutenzalutam
BACKGROUND There are many pharmacologic therapies that are being used or considered for treatment of COVID-19. There is a need for frequently updated practice guidelines on their use, based on critical evaluation of rapidly emerging literature. OBJECTIVE Develop evidence-based rapid guidelines intended to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19. METHODS IDSA formed a multidisciplinary guideline panel of infectious disease clinic
Like
Comment
Share
